STOCK TITAN
  1. Home
  2. News
  3. SYK

Stryker Corporation - SYK STOCK NEWS

Welcome to our dedicated page for Stryker Corporation news (Ticker: SYK), a resource for investors and traders seeking the latest updates and insights on Stryker Corporation stock.

Stryker Corporation, based in Kalamazoo, Michigan, is an American multinational renowned for its groundbreaking medical technologies. The company designs, manufactures, and markets a wide array of medical equipment and devices that play critical roles in healthcare settings around the globe.

Stryker's comprehensive product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds, gurneys, and spinal devices. The company is a dominant force in the medical sector, holding a top-three position in reconstructive orthopedic implants and leading in operating room equipment.

In the most recent financial updates, Stryker reported impressive operating results for the fourth quarter and the full year of 2023. With organic sales growth exceeding 11% and surpassing $20 billion in sales, the company has shown robust performance. Kevin Lobo, Chair and CEO, attributes this success to the dedicated teams driving high growth and strong adjusted earnings.

Stryker's influence extends globally, impacting over 150 million patients annually through its work in MedSurg, Neurotechnology, Orthopaedics, and Spine. Just over a quarter of its total revenue is generated from markets outside the United States, highlighting its international presence and reach.

The company continues to innovate and expand its horizons. For instance, Stryker will disclose its financial results for the first quarter of fiscal year 2024 on April 30, 2024. This forthcoming report is anticipated to provide further insights into the company’s financial health and ongoing projects.

For those interested in staying updated, Stryker's press releases and financial disclosures are readily available on their website. The corporation maintains a strong commitment to improving healthcare outcomes and enhancing patient care through its innovative products and services.

News

First shoulder arthroplasty surgeries using Stryker’s Blueprint® Mixed Reality Guidance System completed in Europe

Rhea-AI Summary
Stryker (SYK) introduces Blueprint Mixed Reality Guidance System for shoulder arthroplasty surgeries in Europe, enhancing precision and customization for surgeons.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
none
-
News

Stryker showcases commitment to innovation at AAOS 2024 Annual Meeting

Rhea-AI Summary
Stryker introduces Triathlon Hinge and showcases Mako SmartRobotics at AAOS 2024, emphasizing innovation and commitment to surgical excellence. Triathlon Hinge offers versatility and simplicity in revision knee implant options, addressing challenges in complex cases. Mako aims to reduce intra-operative fluoroscopy in hip replacement, enhancing surgical accuracy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
none
-
News

Stryker declares a $0.80 per share quarterly dividend

Rhea-AI Summary
Stryker (SYK) has declared a quarterly dividend of $0.80 per share, representing a 6.7% increase from the prior year. The dividend is payable on April 30, 2024, to shareholders of record on March 29, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
dividends
News

Stryker to participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day

Rhea-AI Summary
Stryker (SYK) to participate in Citi's 2024 Unplugged Medtech and Life Sciences Access Day, with company representatives presenting at Citigroup Headquarters in New York. The webcast of the presentation will be available on Stryker's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
conferences
-
News

Stryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and Ankle

Rhea-AI Summary
Stryker (SYK) launches Prophecy Footprint, expanding the Prophecy Surgical Planning system to offer comprehensive surgical planning across the entire foot. The system will be demonstrated at the American College of Foot and Ankle Surgeons Annual Meeting. Also, the company celebrates the tenth anniversary of the Infinity Total Ankle System, with a 98.8% survivorship at the two-year mark.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.95%
Tags
none
-
News

Stryker reports 2023 operating results and 2024 outlook

Rhea-AI Summary
Stryker (NYSE:SYK) reported strong financial results for the fourth quarter and full year of 2023, with net sales increasing 11.8% to $5.8 billion in the quarter and 11.1% to $20.5 billion for the full year. Adjusted EPS increased 15.3% to $3.46 in the quarter and 13.5% to $10.60 for the full year. The company expects 2024 organic net sales growth to be in the range of 7.5% to 9.0% and adjusted net earnings per diluted share to be in the range of $11.70 to $12.00.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.95%
Tags
earnings
News

New Intermediate Nail and RC Lag Screw Expand Gamma4 Portfolio to Meet the Needs of Surgeons and Their Patients

Rhea-AI Summary
Stryker's Gamma4 Hip Fracture Nailing System has been used in over 19,000 cases since its launch in August 2022, across more than 850 facilities. The system has expanded with the addition of an intermediate nail, the RC Lag Screw, and an anti-rotation clip with sleeve components. It is indicated for the treatment of stable and unstable fractures, as well as for bone stabilization and correction of deformities in various regions of the femur. The press release emphasizes Stryker's commitment to providing innovative orthopaedic solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
none
-
News

First Shoulder Arthroplasty Surgeries Using Stryker’s Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph’s Health Care London in Canada

Rhea-AI Summary
Stryker (SYK) announces successful completion of the first shoulder arthroplasty surgeries using Blueprint Mixed Reality (MR) Guidance, a new tool for surgeons to execute pre-operative plans with 3D imaging and operate with more precision and consistency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.49%
Tags
none
-
News

Stryker announces 2023 sales surpassed $20 billion

Rhea-AI Summary
Stryker (SYK) achieved a historic milestone by surpassing $20 billion in annual sales for the first time in December 2023. Kevin Lobo, Chair and CEO, expressed excitement over this achievement, highlighting the positive impact on customers and patients. Stryker will provide further details on its 2023 financial performance during the Q4 and Full Year Earnings Call on January 30, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
none
News

Stryker to announce financial results for its fourth quarter and full year 2023

Rhea-AI Summary
Stryker (NYSE:SYK) will report financial results for Q4 and full year 2023 on January 30, 2024. The press release will include summary financial information, and a webcast will be hosted to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
earnings

FAQ

What is the current stock price of Stryker Corporation (SYK)?

The current stock price of Stryker Corporation (SYK) is $389.76 as of December 4, 2024.

What is the market cap of Stryker Corporation (SYK)?

The market cap of Stryker Corporation (SYK) is approximately 148.6B.

What does Stryker Corporation specialize in?

Stryker Corporation specializes in designing, manufacturing, and marketing medical equipment and devices, including orthopedic implants, endoscopy systems, and operating room equipment.

Where is Stryker Corporation headquartered?

Stryker Corporation is headquartered in Kalamazoo, Michigan, USA.

How did Stryker perform financially in 2023?

Stryker reported excellent organic sales growth of over 11% for both the fourth quarter and the full year of 2023, surpassing $20 billion in sales.

What is the scope of Stryker's global impact?

Stryker impacts over 150 million patients annually and generates just over a quarter of its total revenue from outside the United States.

What are some of the products offered by Stryker?

Stryker's products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds, gurneys, and spinal devices.

When will Stryker report its financial results for Q1 2024?

Stryker will report its financial results for the first quarter of fiscal year 2024 on April 30, 2024.

How can I access Stryker's financial reports?

Stryker's financial reports and press releases can be accessed on their website under the Press Releases and Events & Presentations sections.

Who should I contact for investor inquiries at Stryker?

For investor inquiries, contact Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com.

What areas does Stryker focus its innovations on?

Stryker focuses its innovations on MedSurg, Neurotechnology, Orthopaedics, and Spine to improve patient and healthcare outcomes.

How can I stay updated with Stryker's latest developments?

You can stay updated with Stryker's latest developments by following their press releases and financial disclosures available on their website.

Stock SYK logo
Stryker Corporation

NYSE:SYK

SYK Rankings

#84 Ranked by Market Cap
#1878 Ranked by Dividends

SYK Stock Data

148.58B
360.31M
5.38%
80.33%
1.25%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
PORTAGE